These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1810053)

  • 1. [The treatment of protracted forms of Flexner dysentery].
    Iushchuk ND; Frolov VM; Peresadin NA
    Ter Arkh; 1991; 63(11):19-22. PubMed ID: 1810053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy of quercetin and tocopherol acetate in treating patients with Flexner's dysentery].
    Frolov VM; Peresadin NA; Khomutianskaia NI; Pshenichnyĭ IIa
    Lik Sprava; 1993 Apr; (4):84-6. PubMed ID: 8209460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunomodulating effect of sodium nucleinate in chronic infectious-allergic urticaria].
    Zemskov VM; Poroshina IuA; Luss LV; Belostotskaia OI; Mikheeva GN
    Ter Arkh; 1990; 62(9):111-6. PubMed ID: 2281392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [RNA as a modulator of secondary immunological deficiency and dysnucleotidosis].
    Zemskov AM; Zemskov VM; Perederiĭ VG; Borisova AM; Provotorov VM
    Antibiotiki; 1982; 27(9):704-10. PubMed ID: 7149695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The therapeutic efficacy of sodium nucleinate and monoribonucleotides based on keratoconjunctival test data].
    Zemskov AM; Trutnev BD; Popova VP; Salomakhin GG; Dolzhanov AIa; Mikstaĭs IuIa
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (5):71-4. PubMed ID: 8067149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The clinico-pathogenetic significance of disorders of the immune status in dysentery].
    Iushchuk ND; Frolov VM; Peresadin NA; Kalender SD
    Ter Arkh; 1990; 62(11):36-9. PubMed ID: 2094988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of sodium nucleinate in acute dysentery in children].
    Ionusova KhA; Shoiinov M; Nazarov Sh
    Pediatriia; 1982 Dec; (12):42-3. PubMed ID: 7162888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Humoral and cellular immunity in patients with acute dysentery].
    Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN
    Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The efficacy of combined immunomodulatory therapy with timoptin and sodium nucleinate in patients with chronic obstructive bronchitis].
    Zemskov AM; Zemskov VM; Nikitin AV; Zazhireĭ VD; Evstratova EF
    Ter Arkh; 1989; 61(3):65-8. PubMed ID: 2741121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of severe dysentery].
    Shakhmardanov MZ; Luchshev VI; Isaeva NP; Bondarenko VM
    Klin Med (Mosk); 1997; 75(11):69-71. PubMed ID: 9490365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of sodium nucleinate in treating periodontosis].
    Zemskov MV; Zemskov VM; Gurina ZA; Nerobeev AI
    Stomatologiia (Mosk); 1982; (2):23-5. PubMed ID: 6953626
    [No Abstract]   [Full Text] [Related]  

  • 13. [The immune status indices of children with atopic dermatitis during sodium nucleinate therapy].
    Mazina NM; Avdeeva ZhI; Mannanov AM
    Vestn Dermatol Venerol; 1990; (10):45-9. PubMed ID: 2278195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of sodium nucleinate in clinical practice].
    Keleberda KIa; Baranova TV
    Probl Tuberk; 1988; (8):69-72. PubMed ID: 3059344
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined immunocorrection--a prospective method for treating secondary immunodeficiency].
    Perederiĭ VG; Zemskov AM; Provotorov VM; Nikitin AV; Evstratova EF
    Vrach Delo; 1989 Jan; (1):96-8. PubMed ID: 2718463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prospects for using thymalin in treating bacterial intestinal infections].
    Ivanov KS; Boĭko IN; Bilyk AI; Khavinson VKh
    Voen Med Zh; 1987 Aug; (8):38-9. PubMed ID: 3314133
    [No Abstract]   [Full Text] [Related]  

  • 17. [The tocopherol acetate and splenin correction of the immunological disorders in patients with viral hepatitis B].
    Frolov VM; Peresadin NA; Dekaliuk IV; Pshenichnyĭ IIa
    Lik Sprava; 1992 Apr; (4):90-1. PubMed ID: 1441392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enhanced effectiveness of antibiotic therapy with an exogenous lysozyme in dysentery in children].
    Vereshchagin IA; Vereshchagin SI; Zhuravleva OD
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):927-31. PubMed ID: 3936408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of prodigiozan for increasing the effectiveness of the antibiotic therapy of dysentery in children].
    Vereshchagin IA; Zhuravleva OD
    Antibiotiki; 1984 Oct; 29(10):791-4. PubMed ID: 6439109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunoactive drugs in the combined modality therapy of patients with hypothyroidism].
    Epishin AV; Grytsiv VE; Venger EP
    Ter Arkh; 1991; 63(2):88-92. PubMed ID: 2048033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.